Patent Preparation & Prosecution

Patents are often the most important part of a company's valuation, as well as a potential revenue source through license agreements, mergers, acquisitions, and public offerings. In addition, patents are integral to a company's regulatory strategy and market position. Well-prepared patent applications anticipate these aspects of a company's comprehensive IP strategy, and also fit seamlessly with the company's trade secret and know how strategies -- sometimes it is better to know what *not* to patent than to submit an application which would expose your "secret sauce."

Technical fields in which our firm focuses include:

A short list of patents prepared and/or prosecuted by our attorneys and patent agents include:

U.S. Pat. No. 10,671,632 - Automated Pipeline
U.S. Pat. No. 10,545,156 - Diagnostic biomarker to predict women at risk for preterm delivery
U.S. Pat. No. 10,435,727 - An Isolated Codon Optimized Nucleic Acid
U.S. Pat. No. 9,345,498 - Methods of controlling magnetic nanoparticles to improve vascular flow
U.S. Pat. No. 8,722,685 - Pyrazine derivatives and uses thereof in renal monitoring
U.S. Pat. No. 8,685,711 - Methods and compositions for highly sensitive detection of molecules
U.S. Pat. No. 8,217,166 - Polyethylene glycolated superoxide dismutase mimetics
U.S. Pat. No. 8,119,677 - Polyamides containing amino butyric acid-based building blocks
U.S. Pat. No. 8,076,457 - Crystal of a cytochrome-ligand complex and methods of use
U.S. Pat. No. 7,964,573 - Regulating expression of transient receptor potential channel genes
U.S. Pat. No. 7,749,720 - Methods of identifying compounds for producing insulin sensitization
U.S. Pat. No. 7,589,171 - Polyamides for treating human papilloma virus
U.S. Pat. No. 7,407,645 - Bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands
U.S. Pat. No. 7,238,525 - Strategy for leukemia therapy
U.S. Pat. No. 6,660,849 - Plant fatty acid synthases and use in improved methods for production of medium-chain fatty acids